Impact of adjuvant chemotherapy for patients with locally advanced upper tract urothelial carcinoma in real-world clinical practice.

Teishima, Jun; Hirata, Junichiro; Toge, Takuya; Uematsu, Riku; Mita, Yoshie; Yoshii, Takahiko; Nakamura, Ichiro

Teishima, Jun; Hirata, Junichiro; Toge, Takuya; Uematsu, Riku; Mita, Yoshie; Yoshii, Takahiko; Nakamura, Ichiro.

Afiliação

Teishima J; Department of Urology, Kobe City Hospital Organization Kobe City Medical Center West Hospital, Kobe, Japan.
Hirata J; Department of Urology, Kobe City Hospital Organization Kobe City Medical Center West Hospital, Kobe, Japan.
Toge T; Department of Urology, Kobe City Hospital Organization Kobe City Medical Center West Hospital, Kobe, Japan.
Uematsu R; Department of Urology, Kobe City Hospital Organization Kobe City Medical Center West Hospital, Kobe, Japan.
Mita Y; Department of Urology, Kobe City Hospital Organization Kobe City Medical Center West Hospital, Kobe, Japan.
Yoshii T; Department of Urology, Kobe City Hospital Organization Kobe City Medical Center West Hospital, Kobe, Japan.
Nakamura I; Department of Urology, Kobe City Hospital Organization Kobe City Medical Center West Hospital, Kobe, Japan.

Can Urol Assoc J ; 18(1): E32-E36, 2024 Jan.

Article em En | MEDLINE | ID: mdl-37812794

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Can Urol Assoc J Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Japão País de publicação: Canadá

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google